A phase II trial of Naloxone PRT in Opioid Induced Constipation.

Trial Profile

A phase II trial of Naloxone PRT in Opioid Induced Constipation.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs Naloxone (Primary)
  • Indications Constipation
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Mar 2016 New trial record
    • 25 Feb 2016 According to a Algobate media release, the company successfully completed an end-of-phase 2 meeting with the U.S. Food and Drug Administration (FDA) for oral naloxone tablet for the treatment of opioid induced constipation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top